Medical Condition News

RSS

CTRC researcher receives special $1.62 million orphan disease grant from FDA

A researcher at the Cancer Therapy & Research Center is the leader on a study receiving a special $1.62 million orphan disease grant from the Food & Drug Administration.

5 Oct 2014

Damage to right frontal-subcortical network may cause ipsilateral spatial neglect

Stroke researchers have confirmed that damage to the right frontal-subcortical network may cause ipsilateral spatial neglect. Among individuals with ipsilateral neglect, a much greater proportion had frontal subcortical damage than anticipated by the investigators - 83% vs the expected 27%.

5 Oct 2014

Kessler Foundation, NJHF partner to advance biomedical research

The signing of a formal affiliation agreement that allows Kessler Foundation and New Jersey Health Foundation to work together to advance biomedical research, education and patient care programs has been announced by Rodger DeRose, president and chief executive officer of Kessler Foundation and James M. Golubieski, president of New Jersey Health Foundation.

5 Oct 2014

Eli Lilly to discontinue development of tabalumab due to insufficient efficacy in Phase 3 Lupus trials

Eli Lilly and Company announced today it will discontinue development of tabalumab -- being studied for the treatment of systemic lupus erythematosus (SLE, commonly known as lupus) -- due to insufficient efficacy in two pivotal Phase 3 trials. The decision was not based on safety concerns.

3 Oct 2014

TxCell to highlight development, progress of ASTrIA platform at 13th Annual BIO Investor Forum

TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today Damian Marron, CEO, TxCell will be presenting at the 13th Annual BIO Investor Forum, October 7-8, 2014 at the Palace Hotel in San Francisco, California, US.

3 Oct 2014

Leading experts urge Canadian health-care providers to improve care for people living with SCI

Leading Canadian spinal cord injury (SCI) experts have launched the unprecedented Spinal Cord Injury: A Manifesto for Change—a call to action and a plea for Canadian health-care providers and stakeholders to work in coordination to improve care and the health of people living with SCI in Canada.

3 Oct 2014

CytoSorbents announces launch of International CytoSorb Treatment Registry

CytoSorbents Corporation, a critical care immunotherapy company using blood purification to treat life-threatening conditions, announced the launch of its International CytoSorb Treatment Registry, established and managed by the Center of Clinical Trials at the University of Jena, Germany.

3 Oct 2014

Halozyme's PEGPH20 receives FDA Orphan Drug designation for treatment of pancreatic cancer

Halozyme Therapeutics, Inc. today announced that the U.S. Food and Drug Administration has granted Orphan Drug designation for PEGylated recombinant human hyaluronidase (PEGPH20) for the treatment of pancreatic cancer.

3 Oct 2014

TyrRS enzyme protects DNA during cellular stress

Scientists at The Scripps Research Institute have found that an enzyme best known for its fundamental role in building proteins has a second major function: to protect DNA during times of cellular stress.

3 Oct 2014

LA BioMed researchers report that THC may help protect the brain of traumatic brain injury patients

Surveying patients with traumatic brain injuries, a group of Los Angeles Biomedical Research Institute researchers reported today that they found those who tested positive for THC, the active ingredient in marijuana, were more likely to survive than those who tested negative for the illicit substance.

3 Oct 2014

Energy drinks increase frequency of insomnia, nervousness in athletes

A study analysing the positive and negative effects of energy drinks on athletes has seen that, although in principle their sports performance was seen to improve by between 3% and 7%, there was also an increase in the frequency of insomnia, nervousness and the level of stimulation in the hours following competition.

3 Oct 2014

Diet may influence susceptibility to autoinflammatory bone disease in at-risk individuals

Diet-induced changes in the gut's bacterial ecosystem can alter susceptibility to an autoinflammatory bone disease by modifying the immune response, St. Jude Children's Research Hospital scientists reported. The findings appeared September 28 as an advanced online publication of the scientific journal Nature.

3 Oct 2014

Montmorency cherry concentrate helps reduce effects of gout

Drinking Montmorency concentrate significantly helps to reduce the effects of the painful condition gout, according to new research.

3 Oct 2014

Benefits of low-carbohydrate diet for patients with type 2 diabetes

Low-carbohydrate diet has a good effect not only on blood glucose, but also on physical functions, bodily pain and general health, according to a diet study including patients with type 2 diabetes.

3 Oct 2014

Humalog 200 units/ml KwikPen insulin gets marketing approval in EU for treatment of diabetes

Eli Lilly and Company today announced that the European Commission has granted marketing authorisation for Humalog 200 units/ml KwikPen (insulin lispro 200 units/ml) for the treatment of diabetes in adults.

3 Oct 2014

Blood test can help identify people at increased risk of atrial fibrillation, stroke

Many of those who are genetically predisposed to develop atrial fibrillation, which dramatically raises the risk of stroke, can be identified with a blood test. This is shown by new research from Lund University in Sweden.

3 Oct 2014

Chronic consumption of melatonine helps combat obesity, diabetes

Scientists at the University of Granada, in collaboration with La Paz University Hospital in Madrid and the University of Texas, San Antonio in the US have demonstrated through several experiments conducted on Zucker obese rats that chronic consumption of melatonine helps combat obesity and diabetes mellitus type two.

3 Oct 2014

Large number of Canadian stroke patients not getting help to get back to active life

Too many stroke patients in Canada are not getting the rehabilitation they need to return to a healthy, active life, according to a new study which will be presented at the Canadian Stroke Congress in Vancouver tomorrow.

3 Oct 2014

ERK and JNK enzymes may offer solutions for treating endometrial, colon cancers

In the quest to solve cancer's mysteries, they come in handy when describing tongue-twisting processes and pathways that somehow allow tumors to form and thrive. Two examples are ERK (extracellular-signal-related kinase) and JNK (c-June N-Terminal Kinase), enzymes that may offer unexpected solutions for treating some endometrial and colon cancers.

3 Oct 2014

Genoscience Pharma to present novel cancer therapeutic strategy at EORTC-NCI-AACR Symposium

Genoscience Pharma, a company focused on discovering and developing small molecules to treat cancer by targeting cancer stem cells, today announces that it will present data on its most promising candidate at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, in Barcelona, Spain, on November 18-21, 2014.

3 Oct 2014

Medical Condition News

CTRC researcher receives special $1.62 million orphan disease grant from FDA

Damage to right frontal-subcortical network may cause ipsilateral spatial neglect

Kessler Foundation, NJHF partner to advance biomedical research

Eli Lilly to discontinue development of tabalumab due to insufficient efficacy in Phase 3 Lupus trials

TxCell to highlight development, progress of ASTrIA platform at 13th Annual BIO Investor Forum

Leading experts urge Canadian health-care providers to improve care for people living with SCI

CytoSorbents announces launch of International CytoSorb Treatment Registry

Halozyme's PEGPH20 receives FDA Orphan Drug designation for treatment of pancreatic cancer

TyrRS enzyme protects DNA during cellular stress

LA BioMed researchers report that THC may help protect the brain of traumatic brain injury patients

Energy drinks increase frequency of insomnia, nervousness in athletes

Diet may influence susceptibility to autoinflammatory bone disease in at-risk individuals

Montmorency cherry concentrate helps reduce effects of gout

Benefits of low-carbohydrate diet for patients with type 2 diabetes

Humalog 200 units/ml KwikPen insulin gets marketing approval in EU for treatment of diabetes

Blood test can help identify people at increased risk of atrial fibrillation, stroke

Chronic consumption of melatonine helps combat obesity, diabetes

Large number of Canadian stroke patients not getting help to get back to active life

ERK and JNK enzymes may offer solutions for treating endometrial, colon cancers

Genoscience Pharma to present novel cancer therapeutic strategy at EORTC-NCI-AACR Symposium

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Latest News